Subjects: Drug Compounding -- standards and Phenylketonurias -- drug therapy - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Drug Compounding -- standards ✖ Subjects Phenylketonurias -- drug therapy ✖

1. Compliance policy for certain compounding of oral oxitriptan (5-HTP) drug products for patients with tetrahydrobiopterin (BH4) deficiency: immediately in effect guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, July 2019
Subject(s):: Drug Compounding -- standards
5-Hydroxytryptophan -- therapeutic use
Phenylketonurias -- drug therapy
Guideline Adherence
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.